Viggo Jønsson

Professor Emeritus - Department of Haematology
Image of Viggo Jønsson
Norwegian version of this page
Username
Visiting address Sognsvannsveien 20 Rikshospitalet 0372 OSLO

Publications

  • Jønsson, Viggo; Awan, Haneef; Jones, Neil D.; Johannessen, Tom Børge; Steig, Bjarni A; Andosdottir, Gudrid & Tjønnfjord, Geir Erland (2019). Inheritance of Susceptibility to Malignant Blood Disorders. Scientific Reports.  ISSN 2045-2322.  9, s 1- 12 . doi: 10.1038/s41598-019-38879-y Full text in Research Archive.
  • Awan, Haneef; Furuholmen, Johanna; Tjønnfjord, Geir Erland; Ly, Bernt; Johannesen, Tom Børge; Tierens, Anne; Delabie, Jan & Jønsson, Viggo (2014). Segregation of Malignant Hematological Disease in Families with Malignant Lymphoma. Journal of genetic syndrome & gene therapy.  ISSN 2157-7412.  5(6)
  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom Børge & Tjønnfjord, Geir Erland (2014). Chronic Lymphocytic Leukemia, Advantages of Monoclones?. Journal of Leukemia.  ISSN 2329-6917.  2(3)
  • Mulligan, Stephen; Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Gill, Devinder S.; Hammerstrøm, Jens; Hertzberg, Michael; McLennan, Roger; Uggla, Bertil; Norman, John; Wallvik, Jonas; Sundström, Gunnel; Johansson, Hemming; Brandberg, Yvonne; Liliemark, Jan & Juliusson, Gunnar (2014). Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia. Leukemia and Lymphoma.  ISSN 1042-8194.  55(12), s 2769- 2777 . doi: 10.3109/10428194.2014.893306
  • Tjønnfjord, Geir Erland; Jønsson, Viggo; Ly, Bernt Erik & Johannessen, Tom Børge (2012). Familiær forekomst av kronisk lymfatisk leukemi i Norge. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  132(18), s 2060- 2063 . doi: 10.4045/tidsskr.11.1350 Show summary
  • Tjønnfjord, Geir Erland; Ly, Bernt Erik; Johannesen, Tom Børge; Tierens, Anne; Beiske, Klaus; Heim, Sverre & Jønsson, Viggo (2012). Kronisk lymfatisk leukemi i Norge – insidens og prognose ved diagnosetidspunktet. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  132(18), s 2056- 2059 . doi: 10.4045/tidsskr.11.1349 Show summary
  • Jønsson, Viggo; Awan, Haneef; Nyquist, Emil; Maisenhölder, Martin; Johannesen, Tom Børge; Ly, Bernt Erik & Tjønnfjord, Geir Erland (2011). Familial Hodgkin's Lymphoma in Scandinavia. In Vivo.  ISSN 0258-851X.  25(3), s 431- 437
  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom B.; Ly, Bernt & Tjønnfjord, Geir Erland (2010). Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders. Translational Oncogenomics.  ISSN 1177-2727.  4, s 1- 9
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Johannesen, Tom Børge; Ly, Bernt Erik; Olsen, Jørgen H & Yuille, Martin (2010). Familial Chronic Lymphocytic Leukemia in Norway and Denmark. Comments on Pleiotropy and Birth Order. In Vivo.  ISSN 0258-851X.  24(1), s 85- 95
  • Crowther-Swanepoel, D; Wild, R; Sellick, G; Dyer, MJS; Mauro, FR; Cuthbert, RJG; Jønsson, Viggo; Matutes, E; Dearden, C; Wiley, J; Fuller, S; Catovsky, D & Houlston, RS (2008). Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL. Blood.  ISSN 0006-4971.  111, s 5691- 5693 . doi: 10.1182/blood-2008-03-142349
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Johannesen, T.B.; Samuelsen, Sven Ove & Ly, Bernt Erik (2008). Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders. Translational Oncogenomics.  ISSN 1177-2727.  3, s 1- 6
  • Olsen, AL; Johannesen, TB; Ly, Bernt Erik; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & Jønsson, Viggo (2008). Pleiotropy in families with chronic lymphocytic leukemia. Salud (i) Ciencia.  ISSN 1667-8982.  15, s 1236- +
  • Jønsson, Viggo; Hasselbalch, Hans & Christensen, Bjarne Egelund (2007). Blodsygdomme, I: Torben V. Schroeder; Svend Schulze; Jannik Hilsted & Liv Gøtzsche (red.),  Basisbog i Medicin & Kirurgi.  Munksgaard Danmark.  ISBN 978-87-628-0573-6.  Kapitel 21.  s 693 - 736
  • Jønsson, Viggo; Hasselbalch, Hans & Christensen, Bjarne Egelund (2007). Jern, B-vitaminer og medikamentel knoglemarvspåvirkning, I: Jens P. Kampmann; Kim Brøsen & Ulf Simonsen (red.),  Basal og klinisk farmakologi.  FADL's Forlag a/s.  ISBN 978-87-7749-382-9.  Kapitel 58.  s 655 - 64
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Samuelsen, Sven Ove; Johannesen, Tom; Olsen, Jørgen; Sellick, Gabrielle; Houlston, Richard; Yuille, Martin & Catovsky, Daniel (2007). Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease. Leukemia and Lymphoma.  ISSN 1042-8194.  48(12), s 2387- 2396 . doi: 10.1080/10428190701686273
  • Jønsson, Viggo & Johannessen, Tom B (2006). Anticipation in lymphoproliferative disorders. Leukemia and Lymphoma.  ISSN 1042-8194.  47(10), s 2015- 2016
  • Jønsson, Viggo & Olsen, Jørgen H (2006). Arv og lymfoproliferativ sygdom. Ugeskrift for læger.  ISSN 0041-5782.
  • Lotfi, K*; Karlsson, Karin; Fyrberg, A*; Juliusson, G.; Jønsson, Viggo; Peterson, Curt; Eriksson, S & Albertioni, F (2006). The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. Biochemical Pharmacology.  ISSN 0006-2952.
  • Jønsson, Viggo; Houlston, RS; Catovsky, D; Yuille, M; Hilden, J.; Olsen, J.H.; Fajber, M.; Brandt, B.; Sellick, G.; Allinson, R & Wiik, A (2005). CLL family 'Pedigree 14' revisitet: 1947-2004. Leukemia.  ISSN 0887-6924.  19(6), s 1025- 8
  • Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS; Jønsson, Viggo; Langerak, AW; Mauro, FR; Fuller, S; Wiley, J; Lyttelton, M; Callea, V; Yuille, M; Catovsky, D & Houlston, RS (2005). A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. American Journal of Human Genetics.  ISSN 0002-9297.  77, s 420- 429
  • Egelund Christensen, Bjarne & Jønsson, Viggo (2004). Blodsygdomme, I: Torben V. Schroeder; Svend Schulze; Jannik Hilsted & Jan Aldershvile (red.),  Basisbog i medicin og kirurgi.  Munksgaard Forlag.  ISBN 87-628-0402-2.  Kapittelnummer 21.  s 727 - 767
  • Gniadecki, R.; Rossen, K.; Ralfkier, E.; Thomsen, K.; Skovgaard, G.L. & Jønsson, Viggo (2004). CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Archives of Dermatology.  ISSN 0003-987X.  140(4), s 427- 36
  • Jønsson, Viggo & Egelund Christensen, Bjarne (2004). Maligne hæmatologiske sygdomme, I: Ulrik Ringborg; Roger Henriksson & Sten Friberg (red.),  Kræftsygdomme � onkologi.  Fadl's forlag.  ISBN 87-7749-317-6.  Kapittel 33.  s 392 - 411

View all works in Cristin

  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom Børge; Ly, Bernt & Tjønnfjord, Geir Erland (2009). Birth Order Effect in the Inheritance of CLL.
  • Johannesen, Tom Børge; Ly, Bernt Erik; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & Jønsson, Viggo (2008). Ny studie om kronisk lymfatisk leukemi i Norge. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  128(6), s 713
  • Jønsson, Viggo (2008). Birth order effect in the inheritance of chronic lymphocytic leukemia (CLL). Anticancer Research.  ISSN 0250-7005.  28(5c), s 3337
  • Jønsson, Viggo; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & johannesen, tom (2008). Looking for CLL genes. Leukemia and Lymphoma.  ISSN 1042-8194.  49, s 10- 11 . doi: 10.1080/10428190701713705
  • Kolstad, A; Tjonnfjord, G & Jønsson, Viggo (2008). High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT. Bone Marrow Transplantation.  ISSN 0268-3369.  42, s 427- 428 . doi: 10.1038/bmt.2008.183
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Samuelsen, Sven Ove; Johannesen, Tom & Ly, Bernt (2007). Pleiotrophy in familial CLL. Leukemia and Lymphoma.  ISSN 1042-8194.  48, s 124
  • Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Mulligan, Stephen; Liliemark, Jan & Juliusson, Gunnar (2007). Improved response duration from first-line treatment with cladribine (CdA), as compared to fludarabine (F) of high-dose intermittent chlorambucil (Chl) for first-line treatment of symptomatic chronic lymphocytic leukemia (CLL). First results from the International Randomized Phase III Trial. Leukemia and Lymphoma.  ISSN 1042-8194.  48, s 167- 68
  • Jønsson, Viggo (2006). Arv og kræft. Ugeskrift for læger.  ISSN 0041-5782.
  • Karlsson, K.; Strømberg, M.; Willander, K.; Jønsson, Viggo; Hammerstrøm, J.; Uggla, B.; Wallvik, J.; Sundstrøm, G.; Geisler, C.; Tobin, G.; Rosenquist, R; Liliemark, J. & Juliusson, G. (2005). IgH mutational status is of limited prognostic value in untreated symptomatic CLL patients - results from the prospective International Phase III study. Leukemia and Lymphoma.  ISSN 1042-8194.  46, s 38
  • Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS; Jønsson, Viggo; Langerak, AW; Mauro, FR; Fuller, S; Wiley, J; Lyttelton, M; Callea, V; Yuille, M; Catovsky, D & Houlston, RS (2005). A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia susceptibility loci. Leukemia and Lymphoma.  ISSN 1042-8194.  46, s 60
  • Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Devinder, Gill; Wallvik, Jonas; Mulligan, Stephen; Bradstock, Kenneth; Liliemark, Jan & Juliusson, Gunnar (2004). Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

View all works in Cristin

Published Apr. 13, 2011 2:55 PM - Last modified May 27, 2011 4:13 PM